-
Loading metrics
Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records
-
Christopher F. Bell ,
Roles Conceptualization, Formal analysis, Validation, Writing – review & editing
* E-mail: christopher.f.bell@gsk.com
Affiliation GSK, Durham, North Carolina, United States of America
⨯ - Daniel C. Gibbons,
- Myriam Drysdale,
- Helen J. Birch,
- Emily J. Lloyd,
- Vishal Patel,
- Corinne Carpenter,
-
Katherine Carlson,
Roles Conceptualization, Data curation, Formal analysis, Validation, Writing – review & editing
Affiliation nference, Cambridge, Massachusetts, United States of America
⨯ - Ediz S. Calay,
- Arjun Puranik,
- Tyler E. Wagner,
-
John C. O’Horo,
Roles Conceptualization, Data curation, Formal analysis, Validation, Writing – review & editing
Affiliation Mayo Clinic, Rochester, Minnesota, United States of America
⨯ - Raymund R. Razonable
https://orcid.org/0000-0001-6413-2537
Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic electronic health records
- Christopher F. Bell,
- Daniel C. Gibbons,
- Myriam Drysdale,
- Helen J. Birch,
- Emily J. Lloyd,
- Vishal Patel,
- Corinne Carpenter,
- Katherine Carlson,
- Ediz S. Calay,
- Arjun Puranik
x
- Published: July 16, 2024
- https://doi.org/10.1371/journal.pone.0304822